Susan Blum - 23 Jan 2026 Form 4 Insider Report for CorMedix Inc. (CRMD)

Reporting relationship: Chief Financial Officer
Issuer ticker: CRMD
Reported as of: 23 Jan 2026
Net transaction value: -$71,006
SEC form: 4
Accepted by SEC: 27 Jan 2026, 21:31:09 UTC
Prior SEC filing: 03 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Beth Zelnick Kaufman, attorney-in-fact

Key filing fact

Susan Blum filed Form 4 for CorMedix Inc. (CRMD) on 27 Jan 2026.

Key facts

This page summarizes Susan Blum's Form 4 filing for CorMedix Inc. (CRMD).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 27 Jan 2026, 21:31.

Change

Previous filing in this sequence was filed on 03 Sep 2025.
Current net transaction value: -$71,006.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001792253 Primary reporting owner

Blum Susan

Relationship: Chief Financial Officer
Address: C/O CORMEDIX INC.,, 389 INTERPACE PKWY, SUITE 450, PARSIPPANY
Signature: /s/ Beth Zelnick Kaufman, attorney-in-fact
Signature date: 27 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRMD transaction

Common Stock

Award

Transaction value: $0
Shares: +72,820
Change %: +104%
Price: $0.000000
Shares after: 142,506
Date: 23 Jan 2026
Ownership: Direct
Footnotes: F1

CRMD transaction

Common Stock

Tax liability

Transaction value: $71,006
Shares: -9,767
Change %: -6.9%
Price: $7.27
Shares after: 132,739
Date: 23 Jan 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares represent restricted stock units granted on 01/23/2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.

SEC remarks

Exhibit 24.1 - Power of Attorney